Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites
Xingxing Diao, Marilyn A. Huestis
Frontiers in Chemistry (2019) Vol. 7
Open Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review
Vera L. Alves, João Gonçalves, Joselin Aguiar, et al.
Critical Reviews in Toxicology (2020) Vol. 50, Iss. 5, pp. 359-382
Closed Access | Times Cited: 156
Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives
Alison C. Burggren, Anaheed Shirazi, Nathaniel D. Ginder, et al.
The American Journal of Drug and Alcohol Abuse (2019) Vol. 45, Iss. 6, pp. 563-579
Open Access | Times Cited: 103
Cannabinoids in the Pathophysiology of Skin Inflammation
Cristian Scheau, Ioana Anca Bădărău, Livia-Gratiela Mihai, et al.
Molecules (2020) Vol. 25, Iss. 3, pp. 652-652
Open Access | Times Cited: 83
An emerging trend in Novel Psychoactive Substances (NPSs): designer THC
Cristian Caprari, E. Ferri, Maria Angela Vandelli, et al.
Journal of Cannabis Research (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 13
The metabolism of the synthetic cannabinoids ADB‐BUTINACA and ADB‐4en‐PINACA and their detection in forensic toxicology casework and infused papers seized in prisons
Robert Kronstrand, Caitlyn Norman, Svante Vikingsson, et al.
Drug Testing and Analysis (2021) Vol. 14, Iss. 4, pp. 634-652
Open Access | Times Cited: 51
Identification of new psychoactive substances and their metabolites using non-targeted detection with high-resolution mass spectrometry through diagnosing fragment ions/neutral loss analysis
José Manuel Matey, Félix Zapata, Luis Manuel Menéndez-Quintanal, et al.
Talanta (2023) Vol. 265, pp. 124816-124816
Closed Access | Times Cited: 20
How to Study the Metabolism of New Psychoactive Substances for the Purpose of Toxicological Screenings—A Follow-Up Study Comparing Pooled Human Liver S9, HepaRG Cells, and Zebrafish Larvae
Lea Wagmann, Fabian Frankenfeld, Yu Mi Park, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 44
In silico prediction, LC-HRMS/MS analysis, and targeted/untargeted data-mining workflow for the profiling of phenylfentanyl in vitro metabolites
Annagiulia Di Trana, Pietro Brunetti, Raffaele Giorgetti, et al.
Talanta (2021) Vol. 235, pp. 122740-122740
Closed Access | Times Cited: 35
ADB‐HEXINACA—a novel synthetic cannabinoid with a hexyl substituent: phase I metabolism in authentic urine samples, a case report and prevalence on the German market
Arianna Giorgetti, Annette Zschiesche, Olwen Groth, et al.
Drug Testing and Analysis (2024) Vol. 16, Iss. 11, pp. 1350-1365
Open Access | Times Cited: 5
QuEChERS Extraction and Simultaneous Quantification in GC-MS/MS of Hexahydrocannabinol Epimers and Their Metabolites in Whole Blood, Urine, and Oral Fluid
Annagiulia Di Trana, Giorgia Sprega, Giorgi Kobidze, et al.
Molecules (2024) Vol. 29, Iss. 14, pp. 3440-3440
Open Access | Times Cited: 5
Biotransformation of the New Synthetic Cannabinoid with an Alkene, MDMB-4en-PINACA, by Human Hepatocytes, Human Liver Microsomes, and Human Urine and Blood
Shimpei Watanabe, Svante Vikingsson, Anna Åstrand, et al.
The AAPS Journal (2019) Vol. 22, Iss. 1
Closed Access | Times Cited: 39
Hyphenated high-resolution mass spectrometry—the “all-in-one” device in analytical toxicology?
Hans H. Maurer
Analytical and Bioanalytical Chemistry (2020) Vol. 413, Iss. 9, pp. 2303-2309
Open Access | Times Cited: 37
Perspectives and challenges associated with the determination of new psychoactive substances in urine and wastewater – A tutorial
Lubertus Bijlsma, Richard Bade, Frederic Béen, et al.
Analytica Chimica Acta (2020) Vol. 1145, pp. 132-147
Closed Access | Times Cited: 36
Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions
Joshua D. Brown, Kevin J. Rivera Rivera, Leilanie Y. Crespo Hernandez, et al.
The Journal of Clinical Pharmacology (2021) Vol. 61, Iss. S2
Open Access | Times Cited: 29
3F-α-pyrrolydinovalerophenone (3F-α-PVP) in vitro human metabolism: Multiple in silico predictions to assist in LC-HRMS/MS analysis and targeted/untargeted data mining
Jérémy Carlier, Diletta Berardinelli, Eva Montanari, et al.
Journal of Chromatography B (2022) Vol. 1193, pp. 123162-123162
Closed Access | Times Cited: 20
Study of metabolism and potential toxicity of nine synthetic opioid analogs using the zebrafish larvae model
Matilde Murari, Sara Pesavento, Francesca Greco, et al.
Drug Testing and Analysis (2023) Vol. 16, Iss. 6, pp. 629-637
Open Access | Times Cited: 11
Analysis of NPS in post-mortem samples in forensic toxicology
José Manuel Matey, Luis Manuel Menéndez-Quintanal, Begoña Bravo Serrano, et al.
Comprehensive analytical chemistry (2025)
Closed Access
In vitro metabolism of Benzyl-4CN-BUTINACA and MDMB-4CN-BUTINACA using human hepatocytes and LC-QToF-MS analysis
Caitlyn Norman, Kristin Webling, Dārta Štālberga, et al.
Archives of Toxicology (2025)
Open Access
In vitro metabolism and metabolite identification of eutylone using rat liver microsomes
Alexandre B. Godoi, Natalícia de Jesus Antunes, Leonardo Costalonga Rodrigues, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025), pp. 116827-116827
Closed Access
Screening, quantification, and confirmation of synthetic cannabinoid metabolites in urine by UHPLC–QTOF–MS
Per Ole M. Gundersen, Olav Spigset, Martin Josefsson
Drug Testing and Analysis (2018) Vol. 11, Iss. 1, pp. 51-67
Open Access | Times Cited: 34
Adding more “spice” to the pot: A review of the chemistry and pharmacology of newly emerging heterocyclic synthetic cannabinoid receptor agonists
Ryan M. Alam, J. J. Keating
Drug Testing and Analysis (2019) Vol. 12, Iss. 3, pp. 297-315
Closed Access | Times Cited: 32
Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy
Bogdan Ionel Tamba, Gabriela Dumitrița Stanciu, Cristina Mariana Urîtu, et al.
Medicina (2020) Vol. 56, Iss. 1, pp. 24-24
Open Access | Times Cited: 28
Metabolism of ADB‐FUBIATA in zebrafish and pooled human liver microsomes investigated by liquid chromatography–high‐resolution mass spectrometry
Xinze Liu, Yiling Tang, Linhao Xu, et al.
Rapid Communications in Mass Spectrometry (2024) Vol. 38, Iss. 9
Closed Access | Times Cited: 3
The State of the Art in Post-Mortem Redistribution and Stability of New Psychoactive Substances in Fatal Cases: A Review of the Literature
Luis Manuel Menéndez-Quintanal, José Manuel Matey, Virginia Gallo González, et al.
Psychoactives (2024) Vol. 3, Iss. 4, pp. 525-610
Open Access | Times Cited: 3
Diagnosing intake and rationalizing toxicities associated with 5F-MDMB-PINACA and 4F-MDMB-BINACA abuse
Wen Lie, Eleanor Jing Yi Cheong, Evelyn Mei Ling Goh, et al.
Archives of Toxicology (2020) Vol. 95, Iss. 2, pp. 489-508
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top